Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
30.88
+0.34 (1.11%)
At close: Jun 26, 2026, 4:00 PM EDT
31.49
+0.61 (1.98%)
After-hours: Jun 26, 2026, 6:39 PM EDT
Immunocore Holdings Employees
Immunocore Holdings had 524 employees as of December 31, 2025. The number of employees increased by 31 or 6.29% compared to the previous year.
Employees
524
Change (1Y)
31
Growth (1Y)
6.29%
Revenue / Employee
$787,809
Profits / Employee
-$52,607
Market Cap
1.57B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Maravai LifeSciences Holdings | 416 |
| Capricor Therapeutics | 231 |
| Zenas BioPharma | 167 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| ArriVent BioPharma | 77 |
| Savara | 70 |
IMCR News
- 27 days ago - Immunocore presents updated results from Phase 1/2 trial of brenetafusp - TheFly
- 27 days ago - Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma - GlobeNewsWire
- 6 weeks ago - Immunocore Holdings Slides: Corporate presentation - Filings
- 7 weeks ago - Immunocore reports first quarter financial results and provides a business update - GlobeNewsWire
- 7 weeks ago - Immunocore Holdings Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Immunocore Holdings Earnings release: Q1 2026 - Filings
- 2 months ago - Immunocore announces five-year overall survival data for Kimmtrak - TheFly
- 2 months ago - KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma - GlobeNewsWire